Research shows that estrogen can be used to conunteract nerve cell degeneration caused by MS without increased risks of breast and uterine cancers.

Researchers have proposed a new treastment for multiple sclerosis (MS) that utilizes that hormone estrogen to stave off and even reverse some of the mysterious disease's debilitating symptoms without that dangerous side effects of some other hormone therapies.

MS is largely believed to be an autoimmune disease in which the immune system turns on healthy tissue--in this case in the brain and nervous system.  Current treatments include medicines designed to suppress an overative immune system and reduce inflammation, a first-line response of the immune system.  Wherease Copaxone and other such drugs often improve some of the muscle weakness and movement issues associated with the condition, they do little to combat the accompanying neurodegeneration.